GEODE CAPITAL MANAGEMENT, LLC

Holdings History for Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

Symbol: LPCN on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$501,544	62,450	+1,374	+2.2%	$8.03	Q4 2025
30 Sep 2025	0%	0%	$174,703	61,076	0		$2.86	Q3 2025
30 Jun 2025	0%	0%	$193,026	61,076	+2,242	+3.8%	$3.16	Q2 2025
31 Mar 2025	0%	0%	$187,125	58,834	+1,370		$3.18	Q1 2025
31 Dec 2024	0%	+0%	$280,474	57,464	+3,248	+6%	$4.88	Q4 2024
30 Sep 2024	0%	0%	$243,467	54,216	+1,037	+2%	$4.49	Q3 2024
30 Jun 2024	0%	+0%	$438,267	53,179	+4,325	+8.9%	$8.24	Q2 2024
31 Mar 2024	0%	0%	$254,085	48,854	0		$5.20	Q1 2024
31 Dec 2023	0%	0%	$134,858	48,854	0		$2.76	Q4 2023
30 Sep 2023	0%	0%	$143,656	48,854	+24	+0.05%	$2.94	Q3 2023
30 Jun 2023	0%	+0%	$244,150	48,830	+48,830	NEW	$5.00	Q2 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.